Table 1. From clinical assessment to application of systems biology in MS.
Networks | BASED ON |
---|---|
NEDA status
25
• NEDA 1–3 • NEDA 4 • NEDA 5 • NEDA 6 • NEDA 7 • NEDA 8 |
Clinical event, EDSS, MRI Brain atrophy Cognitive impairment CSF neurofilament level Patients related outcome Oligoclonal bands |
BIOMARKERS
7,
8
Related to cells, structures, metabolic pathways, and inflammatory and degenerative cascades. |
OCB, NAA, Glutamate, IL-12, IL-23, Enolase, NfL,
CXCL13, IL-8, ATP break down products, GFAP, MMP9, MMP3, Th17, Th1/Th17, Chitinase 3, IFN-ϒ, TNF-α, Fetuin-A, Osteopontin, PET (microglia), non-conventional MRI. Others. |
NEURO-IMMUNO-PATHOLOGY
|
Tissue damage resulting from interaction of neurons, glial
cells, immune system cells (B & T-cell lymphocytes, macrophages, dendritic cells), cytokines and antibodies in the CNS |
GENETIC DETERMINANTS
8
|
HLA-DRB1*1501:
• risk for MS • early disease onset. • risk for progression from RRMS to SPMS HLA-DPB1* 0501 & HLA-DPB1* 0301: • risk for opticospinal MS. HLA-DRB1* 1501 & HLA-DQB1* 0301: • worst brain atrophy measures. DR3 & DR4 haplotypes: • risk for MS. TOB1 gen: • early conversion from CIS to CDMS. ApoEƐ4: • greater risk for mental disorders. Pharmacogenomics |
GUT-IMMUNE-BRAIN AXIS
26
The gut-associated lymphoid tissue system (GALT) is located in the intestinal lamina propria, near the epithelium, and consists of: Organized cellular complexes • Peyer’s patches • solitary lymphoid follicles Dispersed cells • T and B cells, macrophages, and dendritic cells |
The human intestinal flora (microbiota) interaction
with GALT could be considered harmless, beneficial or pathogenic depending on the anti-inflammatory or pro-inflammatory state that could result from this interaction. In the later, it could influence immunity and inflammation in the pathophysiology of MS. |
The table shows the dynamic interaction of networks leading to the molecular expression of MS in the preclinical state and through disease span.
Abbreviations in the table: EDSS: Expanded Disability Status Scale; OCB: oligoclonal bands; NAA: N-Acetyl aspartate; IL: interleukin; NfL: light chain sub-unit of neurofilaments; CXCL13: C-X-C Motif Chemokine Ligand 13; ATP: adenosine triphosphate; GFAP: glial fibrillary acidic protein; MMP: matrix metalloproteinase; Th17: IL-17 secreting T-lymphocyte; IFN-ϒ: interferon gamma; TNFα: tumor necrosis factor α; CIS: clinical isolated syndrome; CDMS: clinical definitive multiple sclerosis